S Swaroop Vedula
Affiliation: Johns Hopkins Bloomberg School of Public Health
- Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin litigationS Swaroop Vedula
Department of Epidemiology, Center for Clinical Trials, Johns Hopkins Bloomberg School of Public Health, 615 N, Wolfe Street, Mailroom W5010, Baltimore, MD 21205, USA
Trials 13:136. 2012..migraine prophylaxis, treatment of bipolar disorders, neuropathic pain, and nociceptive pain...
- Network meta-analysis-highly attractive but more methodological research is neededTianjing Li
Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21212, USA
BMC Med 9:79. 2011..Since this commentary reflects the discussion at that meeting, it is not intended to provide an overview of the field...
- Outcome reporting in industry-sponsored trials of gabapentin for off-label useS Swaroop Vedula
Center for Clinical Trials, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
N Engl J Med 361:1963-71. 2009..There is good evidence of selective outcome reporting in published reports of randomized trials...
- Differences in reporting of analyses in internal company documents versus published trial reports: comparisons in industry-sponsored trials in off-label uses of gabapentinS Swaroop Vedula
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
PLoS Med 10:e1001378. 2013..e., what was planned and what was done). Trials were for off-label uses of gabapentin sponsored by Pfizer and Parke-Davis, and documents were obtained through litigation...